[CUE] YoY Quarter Result on 31-Dec-2019 [#Q4]

Stock
[CUE] Cue Biopharma, Inc.
Announcement Date
11-Mar-2020
Financial Year
2019
Quarter
31-Dec-2019 [#Q4]
Profit Trend
QoQ- -27.58%
YoY- 23.26%
Quarter Report
CUE's Result
CUE's Financial Summary
View:
Show?
Quarter Result
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
Revenue 151 8,254 475 1,049 331 0 0 -
PBT -14,592 -7,890 -10,897 -8,918 -10,796 -10,439 -2,842 31.32%
Tax -138 495 206 -1 -825,000 0 0 -
NP -14,454 -8,384 -11,103 -8,918 -11,621 -10,439 -2,842 31.12%
Tax Rate - - - - - - - -
Total Cost 14,605 16,639 11,578 9,967 11,952 10,439 2,842 31.34%
Ratio Analysis
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
NP Margin -9,557.79 -101.57 -2,335.86 -850.14 -3,515.18 0.00 0.00 -
Per Share
31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 CAGR
EPS -0.37 -0.27 -0.37 -0.37 -0.58 -0.51 -0.14 17.57%
EPS Diluted -0.37 -0.27 -0.37 -0.37 -0.56 -0.51 -0.14 17.57%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.